First Wave BioPharma, Inc.·4

Jan 3, 9:07 PM ET

Pennington James 4

4 · First Wave BioPharma, Inc. · Filed Jan 3, 2022

Insider Transaction Report

Form 4
Period: 2022-01-03
Pennington James
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock option (right to buy)

    2022-01-03+7,5007,500 total
    Exercise: $1.45Exp: 2032-01-03Common stock, par value $0.0001 per share (7,500 underlying)
Footnotes (1)
  • [F1]The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Pennington's continued employment by First Wave BioPharma, Inc. on the applicable vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4